Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.39 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | PPME1 | Q9Y570 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14968340 | 0.84 | CYP3A4 (0.43) | MEN1KMT2AL3MBTL1OPRM1LMNA | |
| SCHEMBL9240911 | 0.82 | F10 (0.44) | MEN1KMT2AL3MBTL1ATMCYP2C19 | |
| SCHEMBL191443 | 0.82 | SLC6A3 (0.40) | SIGMAR1LMNA | |
| SCHEMBL24780861 | 0.82 | ITGB1 (0.48) | MEN1KMT2AHTTL3MBTL1TSHR | |
| SCHEMBL14967062 | 0.81 | CHRM3 (0.45) | MEN1KMT2AHTTL3MBTL1OPRM1 | |
| SCHEMBL9774955 | 0.81 | MEN1 (0.38) | MEN1KMT2AHTTTSHROPRM1 | |
| SCHEMBL980214 | 0.81 | OPRM1 (0.54) | L3MBTL1OPRM1 | |
| SCHEMBL14967390 | 0.81 | TSHR (0.41) | MEN1KMT2AHTTTSHROPRM1 | |
| SCHEMBL28120455 | 0.80 | MEN1 (0.39) | MEN1KMT2AHTTL3MBTL1OPRM1 | |
| SCHEMBL10415121 | 0.80 | L3MBTL1 (0.43) | MEN1KMT2AL3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0247946-A1 | Process for neutralizing unpleasant odours of animal excreta | ROBERTET S.A. (FR) | 1987-12-02 | — | — | EP | claimed |
| US-20240253020-A1 | POLYMERIZATION CATALYST FOR OLEFIN POLYMER | JAPAN POLYCHEM CORPORATION (JP) | 2024-08-01 | — | — | US | disclosed |
| US-11970448-B2 | Monomers capable of dimerizing in an aqueous solution, and methods of using same | CORNELL UNIVERSITY (US) | 2024-04-30 | — | — | US | disclosed |
| EP-4317201-A1 | POLYMERIZATION CATALYST FOR OLEFIN-BASED POLYMER | Japan Polychem Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117120484-A | Polymerization catalyst for olefin polymer | 日本聚化株式会社 | 2023-11-24 | — | — | CN | disclosed |
| WO-2022211091-A1 | POLYMERIZATION CATALYST FOR OLEFIN-BASED POLYMER | 日本ポリケム株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-20200354319-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | UNIV CORNELL (US) | 2020-11-12 | — | — | US | disclosed |
| CN-107406371-B | Process for producing 3-phenylisoserine derivative | 东丽精细化工株式会社 | 2020-07-17 | — | — | CN | disclosed |
| EP-3266761-B1 | 3-PHENYLISOSERINE DERIVATIVE PRODUCTION METHOD | TORAY FINECHEMICALS CO LTD (JP) | 2020-05-06 | — | — | EP | disclosed |
| CN-104302173-B | Oil-in-water (O/W) insecticidal preparation | 拜尔农作物科学股份公司 | 2019-10-15 | — | — | CN | disclosed |
| CN-1345721-A | Process for preparing photoactivated (-) yellow skin amide | PHARMACEUTICAL INST CHINESE AC (CN) | 2002-04-24 | — | — | CN | disclosed |
| US-6296865-B1 | USE FOR CONTROLLING INSECTS SUCH AS MOSQUITOES WHICH OCCUR IN INTERIOR ROOMS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-10-02 | — | — | US | disclosed |
| US-6265587-B1 | REACTING ARYLGLYCIDATE WITH A NITRILE TO OBTAIN B-ARYLISOSERINE DERIVATIVE AND TREATING PRODUCT WITH LEWIS ACID TO OBTAIN OXAZOLINE COMPOUND | SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM (FR) | 2001-07-24 | — | — | US | disclosed |
| EP-0332981-B1 | Process for the preparation of esters of alpha-keto-carboxylic acids | BASF AG (DE) | 1994-06-15 | — | — | EP | disclosed |
| EP-0198397-B1 | METHOD OF PRODUCING L-PHENYLALANINE | KURARAY CO., LTD. (JP) | 1993-01-07 | — | — | EP | disclosed |
| US-4968831-A | CATALYTIC REARRANGEMENT OF GLYCIDIC ESTER | BASF AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| EP-0332981-A2 | Process for the preparation of esters of alpha-keto-carboxylic acids | BASF Aktiengesellschaft (DE) | 1989-09-20 | — | — | EP | disclosed |
| US-4743547-A | PURITY, ENZYME HYDROLYSIS | KURARAY CO., LTD. (JP) | 1988-05-10 | — | — | US | disclosed |
| EP-0247946-A1 | Process for neutralizing unpleasant odours of animal excreta | ROBERTET S.A. (FR) | 1987-12-02 | — | — | EP | disclosed |
| EP-0198397-A2 | Method of producing L-phenylalanine | KURARAY CO., LTD. (JP) | 1986-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11970448-B2 | Monomers capable of dimerizing in an aqueous solution, and methods of using same | CALCOCO2, MDN1, MBNL1 | MEN1 199/4885KMT2A 4317/4885HTT 1966/4885 |
| US-20200354319-A1 | MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME | CALCOCO2, MDN1, MBNL1 | MEN1 199/4885KMT2A 4317/4885HTT 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.